Keeps Biopharma Inc. (KOSDAQ:256940)

Keeps Biopharma Ratios and Metrics

Market cap in millions KRW. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jul 21, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	309,990	97,681	119,991	127,866	235,610	309,093
Market Cap Growth	47.05%	-18.59%	-6.16%	-45.73%	-23.77%	428.37%
Enterprise Value	363,303	122,355	160,512	124,281	215,414	294,582
Last Close Price	16250.00	5210.00	6400.00	6820.00	13100.00	20150.00
PE Ratio	-	87.73	30.53	-	-	-
Forward PE	-	3.21	3.21	3.21	3.21	3.21
PS Ratio	2.27	0.77	1.30	8.75	55.30	20.31
PB Ratio	4.42	1.55	2.05	2.45	3.87	6.07
P/TBV Ratio	30.82	8.76	4.50	2.45	3.92	6.28
P/OCF Ratio	-	20.31	-	-	-	-
EV/Sales Ratio	2.66	0.96	1.74	8.50	50.56	19.36
EV/EBITDA Ratio	88.97	13.89	35.65	-	-	1355.37
EV/EBIT Ratio	264.52	19.65	52.45	-	-	-
Debt / Equity Ratio	0.89	0.88	0.83	0.55	0.45	0.41
Debt / EBITDA Ratio	11.19	6.33	10.73	-	-	95.42
Asset Turnover	0.88	0.90	0.91	0.16	0.05	0.26
Inventory Turnover	7.89	8.57	22.90	7.05	4.01	6.10
Quick Ratio	0.51	0.47	0.40	0.99	1.59	1.67
Current Ratio	0.98	0.83	0.84	1.35	2.10	2.29
Return on Equity (ROE)	-4.22%	2.65%	6.25%	-21.28%	-29.03%	-6.27%
Return on Assets (ROA)	1.17%	2.76%	1.89%	-6.23%	-9.03%	-0.42%
Return on Capital (ROIC)	1.48%	3.45%	2.04%	-6.57%	-9.61%	-0.45%
Return on Capital Employed (ROCE)	3.00%	7.80%	5.00%	-	-	-
Earnings Yield	-2.35%	1.14%	3.28%	-8.90%	-6.50%	-0.78%
FCF Yield	-3.28%	-1.83%	-0.87%	-0.75%	-3.60%	-0.90%
Buyback Yield / Dilution	0.20%	-0.38%	-0.40%	-8.22%	-18.22%	-14.07%

Updated Nov 14, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.